Parameter influencing overall survival | HR | 95% CI | p |
---|---|---|---|
Pt. on aspirin (yes vs. no) | 0.357 | 0.149–0.856 | *0.021 |
Not included | |||
Vascular invasion (yes vs. no) | 0.228 | ||
Serum CA19-9 above median | 0.490 | ||
Lymphovascular invasion | 0.440 | ||
Adjuvant chemotherapy | 0.061 | ||
Parameter influencing disease-free survival | |||
Pt. on aspirin (yes vs. no) | 0.316 | 0.158–0.634 | **0.001 |
Vascular invasion (yes vs. no) | 3.008 | 1.541–5.871 | **0.001 |
Not included | |||
Tumor diameter (> median vs. ≤ median) | 0.081 | ||
Lymphovascular invasion | 0.484 | ||
Parameter influencing hematogenous-met-free survival | |||
Pt. on aspirin (yes vs. no) | 0.354 | 0.162–0.772 | *0.009 |
Vascular invasion (yes vs. no) | 4.330 | 2.006–9.344 | **< 0.001 |
Not included | |||
Tumor diameter (> median vs. ≤ median) | 0.065 | ||
Lymphovascular invasion | 0.258 |